Clinical Trials
21 trialsNCT04721886 2026-04-02
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT05859971 2025-07-29
ICG and SLN Mapping
University of Wisconsin, Madison
Phase EARLY_PHASE1 Completed
NCT03514121 2024-11-22
FPA150-001
Five Prime Therapeutics, Inc.
Phase EARLY_PHASE1 Terminated
NCT02913430 2024-09-23
Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT02415387 2024-07-24
IMPACT
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT01383135 2024-01-12
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
Stanford University
Phase EARLY_PHASE1 Completed
NCT01074814 2023-09-28
Side-Out
Translational Drug Development
Phase EARLY_PHASE1 Completed
NCT02065609 2022-10-13
89ZrTrastuzumab Breast Imaging With Positron Emission Tomography
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT01434342 2021-09-28
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT03197389 2021-05-19
Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.
Universitaire Ziekenhuizen KU Leuven
Phase EARLY_PHASE1 Completed
NCT02936999 2020-12-16
Vitamin D Supplementation in Women With DCIS and/or LCIS
Inova Health Care Services
Phase EARLY_PHASE1 Terminated
NCT01823991 2020-07-14
COGNUTRIN in Breast Cancer Survivors
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Completed
NCT01479348 2020-06-02
Imaging Study for FdCyd and THU Cancer Treatment
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT03004534 2020-04-03
A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide
Translational Research in Oncology
Phase EARLY_PHASE1 Completed
NCT03592121 2020-03-12
Study to Investigate the Effect of AB-101 in Breast Cancer Survivors
Applied Biology, Inc.
Phase EARLY_PHASE1 Completed
NCT00331630 2020-03-06
Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
Northwestern University
Phase EARLY_PHASE1 Completed
NCT01730729 2019-09-17
Cabergoline in Metastatic Breast Cancer
Northwestern University
Phase EARLY_PHASE1 Completed
NCT00908791 2019-04-01
Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue
Dartmouth-Hitchcock Medical Center
Phase EARLY_PHASE1 Completed
NCT01313039 2017-02-07
Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer
University of Miami
Phase EARLY_PHASE1 Completed
NCT01805089 2015-03-23
Melatonin Versus Placebo in Breast Cancer
Dana-Farber Cancer Institute
Phase EARLY_PHASE1 Completed
NCT01697345 2014-01-24
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
Creighton University
Phase EARLY_PHASE1 Completed